Research indicates a correlative relationship between asthma and use of consumer cleaning products. We conduct a systematic review of epidemiological literature on persons who use or are exposed to cleaning products, both in occupational and domestic settings, and risk of asthma or asthma-like symptoms to improve understanding of the causal relationship between exposure and asthma. A scoring method for assessing study reliability is presented. Although research indicates an association between asthma and the use of cleaning products, no study robustly investigates exposure to cleaning products or ingredients along with asthma risk. This limits determination of causal relationships between asthma and specific products or ingredients in chemical safety assessment. These limitations, and a lack of robust animal models for toxicological assessment of asthma, create the need for a weight-of-evidence (WoE) approach to examine an ingredient or product's asthmatic potential. This proposed WoE method organizes diverse lines of data (i.e., asthma, sensitization, and irritation information) through a systematic, hierarchical framework that provides qualitatively categorized conclusions using hazard bands to predict a specific product or ingredient's potential for asthma induction. This work provides a method for prioritizing chemicals as a first step for quantitative and scenario-specific safety assessments based on their potential for inducing asthmatic effects. Acetic acid is used as a case study to test this framework.
Introduction
Asthma prevalence is rising globally. Approximately 7% of adults (17.7 million) and 8.6% of children (6.3 million) in the United States have been diagnosed with current asthma, increasing the burden on health care costs and impacting quality of life (Centers for Disease Control and Prevention (CDC), 2015) . Asthma is a complex syndrome with multiple phenotypes (Bousquet et al., 2010) characterized by a combination of smooth muscle dysfunction and inflammatory responses (Lemanske and Busse, 2010; NHLBI, 2007) that commonly presents with symptoms of cough, wheeze, dyspnea, and chest tightness (Tarlo et al., 2008; Association of Occupational and Environmental Clinics (AOEC), 2008) . Most cases of asthma are caused or triggered by specific (IgE-mediated) or non-specific (IgE-independent) inflammation (Mapp et al., 2005) , but exposures to chemical irritants can also cause asthmalike syndromes, like Reactive Airways Dysfunction Syndrome (RADS; Bernstein, 1993; Vandenplas et al., 2014) or Low Intensity Chronic Exposure Dysfunction Syndrome (LICEDS; Baur et al., 2012) . Thus, understanding the subtleties of evaluating asthma as an endpoint in the safety and risk assessment context is an important undertaking. However, risk assessors are hampered by limitations in both epidemiology and toxicology methods, specifically a lack of reliable in vitro or in vivo models for asthma or asthma-specific risk assessment guidance (Maier et al., 2014; 2015) and inadequate exposure characterization.
Interpretation of the potential for cleaning products or individual ingredients to induce asthma (i.e., cause new-onset asthma) or elicit an asthmatic response is an important driver for product formulation decisions and regulatory outcomes. The use of cleaning products in residential and commercial applications is implicated as a potential inducer of asthma or as a trigger for respiratory symptoms in asthmatics, which may contribute to the observed morbidity (Zock et al., 2010; Folletti et al., 2014; Jaakkola and Jaakkola, 2006; Siracusa et al., 2013) . Current evidence is not sufficiently robust to accurately characterize the mixture of chemicals and exposures encountered during cleaning, nor to determine a clear relationship between specific cleaning product exposures and the development of asthma, or asthma induction. Cleaning-related exposures are complex; cleaning can expose individuals to chemical irritants and also temporarily increases intake of dusts, pollen, dander, and molds while simultaneously reducing overall household allergen burdens over time (Nickmilder et al., 2007; Zock et al., 2009; Hern andez-Cadena et al., 2015) . Some studies have conducted quantitative exposure assessments of cleaning scenarios (Bello et al., 2010; Vincent et al., 1993; Nazaroff and Weschler, 2004; Singer et al., 2006; LeBouf et al., 2014; Bessonneau et al., 2013) , but none measured asthmatic or asthma-like outcomes for determination of a quantitative exposure-response relationship.
1 Without linking quantitative exposure assessments to asthma response, the exposure-response relationship between cleaning product ingredients and asthma cannot be characterized and drawing conclusions about specific causal relationships is limited (Hill, 1965; Meek et al., 2014) . Thus, the absence of definitive exposureresponse data is hindering advances in risk management of cleaning-related asthma. Due to the lack of specificity between cleaning activities and asthma induction and, more specifically, a lack of quality quantitative exposure-response estimations, risk assessors are limited to the use of ingredient-specific (i.e., single chemical) toxicological information. However, in the case of asthma, there is no single validated asthma animal model and assessments often use surrogate endpoint data (e.g., sensitization and irritation). This study aims to develop a weight-of-evidence (WoE) approach that can be used to integrate multiple lines of imperfect evidence. We developed a series of risk assessment tools to address this challenge, specifically a multi-step decision system with sequential data analysis techniques and a systematic framework for evaluating weight of evidence to inform hazard characterization and prioritization decisions (Fig. 1) . This prioritization framework is divided into four key steps: systematic review, hazard characterization, safety assessment, and risk management. The procedure uses diverse lines of evidence, specifically human data on asthma and human and animal data on sensitization and irritation to establish a weight-of-evidence category. These tools include an objective study quality evaluation approach that rates epidemiological studies according to their reliability and relevance for asthma safety and risk assessment. Although many high-quality guidelines for evaluating the quality of epidemiological studies exist, they are generally tailored for specific uses (i.e., biomonitoring or exposure evaluation (LaKind et al., 2014) ), disease outcomes (e.g., the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) for neurodevelopmental studies (Whiting et al., 2003) ) or scenarios not relevant for asthma risk assessment. Other guidelines are complex and difficult to interpret and use in a WoE tool that integrates multiple lines of evidence because they lack a method for ranking studies by their quality. Examples include the BEES-C (LaKind et al., 2014) , the PRISMA statement for reporting systematic reviews and meta-analyses (Liberati et al., 2009) , the OHAT approach (NTP, 2013) , the STROBE statement (Von Elm et al., 2008) , and the RCGP three-star system (Nicholson et al., 2010; Baur, 2013) . Our approach aligns with the underlying principles of such methods, but was customized to be flexible and simple in interpretation and easy to integrate with the Klimisch et al. (1997) scoring system widely used for toxicological study evaluation. The approach is expected to facilitate chemical safety assessment.
Our approach includes a systematic review of current epidemiology literature using the quality evaluation tool. The purpose for this review was two-fold: 1) to validate the proposed quality evaluation method and 2) to determine if persons (both adults and children) with and without a history of pre-existing asthma who actively use or are exposed to domestic cleaning products, both in occupational and domestic settings, at least one time per week are at increased risk for asthma or asthma-like symptoms during their lifetime. Domestic cleaning products are defined as products that are commonly available, can be purchased "off the shelf" at local stores, and are typically used in home cleaning scenarios. Specifically, we apply Bradford Hill's criteria for causal association in a chemical safety assessment context (Hill, 1965; Meek et al., 2014) to assess the strength, consistency, temporality, and coherence of the observed associations between cleaning product ingredient exposures and new-onset asthma.
In addition to our presentation of this systematic framework, we apply the methodology to a case study on acetic acid to test the robustness and accuracy of the method (refer to Supplemental Material 1). It is our goal that these methods can be used to enhance understanding of the possible relationship between cleaning product ingredients and asthma despite the knowledge gaps and lack of robust exposure-response information.
Methods
The proposed framework for characterizing and prioritizing chemicals based asthma hazard using a weight-of-evidence method is a multi-step process (see Fig. 1 ). The proposed methods provide guidance for navigating the first two steps of the framework: systematic review and hazard characterization. The third and fourth steps, safety assessment and risk management, are described in detail in Maier et al. (2015) .
Step 1: study Quality Assessment and categorization
The initial step of the proposed multi-step asthma hazard and exposure assessment approach (see Fig. 1 ) is to conduct a systematic review of the literature. In this approach, toxicology data are reviewed and ranked using the Klimisch method for assessing reliability (Klimisch et al., 1997) . Relevant epidemiology studies are critically reviewed and categorized by an internally developed scoring method based on the modified Hill Criteria (Meek et al., 2014) , the principles developed by Klimisch et al. (1997) , and standard epidemiological evaluation practices incorporating the internal and external validity of each study (Lewandowski and Rhomberg, 2005; Money et al., 2013) . Studies are assigned a score ranging from 1 to 4, depending on their reliability and relevance for use in risk assessment (see Table 1 for a description of the scores, their categories, and their interpretation). Reliability, in the context for this report, is defined by the strength of the study design and its ability to validly address the hypothesis of exposure and adverse respiratory health outcome(s). Lower scores are indicative of a more reliable study. Key confounders and effect modifiers should be selected a priori, but can be modified to meet the individual needs of each chemical-specific scenario. Fig. 2 depicts the decision process involved in assigning a study score.
This scoring method was designed to match the categories proposed by Klimisch et al. (1997) so that epidemiology and toxicology evidence can be used concordantly in a WoE evaluation. However, other study quality evaluation methods can also be adapted and used with the proposed WoE and safety assessment methods, as needed. For example, scenarios with complex exposure considerations (e.g., biomarkers) could adopt concepts from the BEES-C method (LaKind et al., 2014) to evaluate exposure measurement quality in more depth than the proposed method, which is based only on categorical judgments regarding population, duration, and temporal patterns (see Fig. 2 ).
Although this system is intended for use in chemical-specific assessments, we conduct a systematic review of the current, relevant epidemiology literature to test and validate the method across a large sample of studies and provide a detailed example of its intended use. A series of terms that relate to both the symptoms and diagnosis of asthma (e.g., wheezing, asthma and airway hyperreactivity) were searched, in conjunction with terms that describe various facets of cleaning products (e.g., laundry and dishwashing), in the National Library of Medicine databases PubMed and TOXLINE. Additional details, including search terms, databases, and inclusion and exclusion criteria are included in the Supplemental Material, Section 1. We included any study that assessed the prevalence of asthma or respiratory symptoms that might be expected from an asthmatic response, referred to as asthma-like symptoms, in both domestic and occupational cleaners. Studies involving persons regularly exposed to sensitizers Relevant, but not reliable for this assessment A study that is likely not internally and/or externally valid. A study that does not address key confounders or biases or directly measure the endpoint of interest, and/or is not directly evaluating a population of interest. 4
Relevant, but reliability cannot be determined from limited documentation. Not useful for this assessment A study that is a literature review or a study with very poor study documentation that precludes evaluating the robustness of its findings.
that are not ingredients found in domestic cleaning products (i.e., nurses who work with glutaraldehyde, Chloramine-T, chlorhexidine, formaldehyde, or benzalkonioum chloride) were excluded (e.g., Lipinska-Ojrzanowska et al., 2014 , 2017 . Studies involving persons working in manufacturing of cleaning products were also excluded (e.g., Abdel Salam et al., 1966; Pham and Mire, 1978; Oleru, 1984; Hendrick et al., 1988; Bernstein et al., 1994) . Although these studies and case reports may be useful for the assessment of health effects and risk associated with specific products (e.g., detergent soaps) or ingredients (e.g., acetic acid, as shown in the case study), the associated exposure levels and durations are likely drastically higher than those encountered by cleaners who use domestic products. For this review, we did not include information regarding enzyme detergents. Only Englishlanguage studies were considered. For this review, only physician-diagnosed cases were considered to be confirmed cases of asthma. We separately analyzed studies that included clinically-diagnosed cases of asthma from those that only evaluated non-specific symptoms. Studies including individuals with no prior diagnosis of asthma (i.e., new-onset asthma cases) were evaluated regardless of underlying etiology (e.g., immunogenic or non-immunogenic). We also included studies on prevalence of respiratory symptoms expected from an asthmatic response, referred to as elicitation or exacerbation of asthma-like symptoms. Key confounders and effect modifiers are considered to be age, race, sex, smoking status, socioeconomic status (SES, a predictor of household indoor air quality), and atopy. 
Step 2: weight of evidence and hazard characterization methodology
The steps in the overall WoE process are shown in Fig. 3 . Because no validated animal models for asthma currently exist, evidence of respiratory sensitization or irritation in animals are evaluated as a potential precursor or inducer of asthma. The analysis assumes one can infer likely respiratory tract responses from assays that involve exposures by routes other than inhalation (e.g., dermal). However, since inhalation data are often not available, the method accommodates the use of data from other routes. The use of surrogate health endpoints for asthma and non-inhalation routes of exposure are reflected in the data hierarchies applied in the WoE process.
Respiratory sensitization is categorized as either present or absent in the WoE analysis. To assess respiratory sensitization potential, multiple lines of evidence are used. Epidemiology studies, case reports and controlled exposure studies in volunteers are given more weight. However, for most chemicals, human effects data on respiratory sensitization are not available. Because there are no fully validated, predictive tests available to identify with a high degree of specificity whether or not a chemical is a respiratory allergen in humans (Anderson et al., 2011; Dotson et al., 2015; Kimber et al., 2011) , the WoE also includes findings from standard sensitization protocols, including those conducted via the dermal route. Due to the complexity of the immune system, species differences in respiratory tract and immune system physiology and anatomy, and experimental challenges involved in conducting inhalation exposure experiments compared to dermal application studies (Arts et al., 2006; Pauluhn et al., 1999) , validated, predictive 2 Other factors are linked to asthma response, specifically parental history of atopy or the presence of household pets, but were not used to judge a study's reliability. The key confounders and effect modifiers listed here are intended to represent the minimum of factors that should be considered in a robust epidemiological study on asthma response.
animal models are lacking.
The ability of a chemical to trigger asthma-like responses is assumed to correlate with the degree of irritation it induces. Because there are inherent uncertainties in extrapolating from irritant potential to asthma potential, data on irritation are placed in one of two broad categories to avoid the suggestion of an unwarranted level of precision in the WoE procedure. Respiratory irritation potential is categorized as (1) none or mild and (2) moderate or severe. The degree of irritation induced by a chemical used for the WoE generally reflects the response to the neat material, although concentration dependent responses are noted when such data are available and as relevant to use scenarios subject to the assessment. This approach of lumping irritation into two categories reflects the intended use of the method to identify chemicals likely to have the potential to cause or elicit asthma responses and prioritize them for more in-depth analysis or data collection.
In the absence of adequate respiratory effects data, data from standard irritation protocols (skin, ocular, and in vitro-based methods) are used to predict respiratory irritation potential. Although eye, skin, and respiratory responses do not always correlate well (Levy and Wegman, 1988) , sensory irritants may act locally in the skin, eye, and respiratory tract mucosae through shared mechanisms which mediate sensations of irritation (Ballantyne, 1999) . Rennen et al. (2002) determined that skin and eye irritants frequently acted as respiratory irritants. Correlations between standard eye irritancy tests and respiratory tract irritancy showed a quantitative relationship between Draize eye scores (eye irritation) and respiratory tract irritant effect levels (ComettoMuniz et al., 2010; TERA, 2010) . For some types of irritants, the underlying mechanisms are likely to be consistent across routes. Such mechanisms may include direct tissue reactivity for corrosive substances (e.g., hydrochloric acid) or activation of transient receptor potential (TRP) ion channels present in nociceptive neurons and various epithelial tissues (e.g., capsaicin, mustard oil) (Caterina et al., 1997; Jordt et al., 2004; Katagiri et al., 2015) .
For each endpoint (asthma, respiratory sensitization, respiratory irritation) a likelihood categorization is assigned based on the WoE (see Table 2 , Fig. 4 ). Individual studies are evaluated for reliability and relevance (see section 2.1) and are assigned a strength of evidence categorization (Table 2) . Although the integration of individual studies and lines of evidence in the WoE assessment reflects the general preference for human inhalation studies, these general preferences are balanced with other considerations related to individual study quality. The endpoint descriptors reflect the robustness of the database identified for each endpoint based on the WoE from the available data.
After assigning a strength of evidence categorization for each of the individual endpoints (asthma, sensitization, and irritation, see Table 2 ), the individual endpoint categories are used to assign a categorization for the overall WoE for asthma (Table 3) . Evidence of respiratory sensitization and irritation in humans is weighed more heavily than in animals when deciding the overall WoE for each chemical. Evidence of respiratory effects (sensitization and irritation) is weighed more heavily than evidence of dermal effects. Although dermal irritation and sensitization data are potential surrogates in the absence of respiratory irritation and sensitization data, the two endpoints are not completely correlated, which adds additional uncertainty to the evaluation.
The overall WoE categorizations can be used as a hazard-based prioritization tool for selecting cleaning product ingredients that are most likely to elicit or induce an asthmatic response and, therefore, need additional assessment. This approach is intended to be conservative and health-protective.
The next steps of the framework for characterizing and prioritizing chemicals (see steps 3 and 4 of Fig. 1 ) are safety assessment and risk management. We have proposed, elsewhere, a tiered safety assessment that integrates both hazard information (including quantitative exposure guidance benchmarks) and exposure assessments that can incorporate cleaning-specific scenarios (see Maier et al., 2015 for methods and details). This tiered approach allows for assessment of most chemicals and scenarios by using lower tiers designed to be precautionary for screening assessment purposes.
Results

Literature review
Our literature search (including tree, or backwards, literature searching) identified 1157 studies related to asthma and cleaning (see Fig. S1 in Supplemental Material 1 for additional details). Based on a review of titles and abstracts, 148 were determined to be potentially relevant for the scope of this assessment. Of these studies, 69 were reviewed and included for consideration in this assessment (i.e., given a reliability score of 1e3. Studies given a score of 4 were not included). Of the 69 reviewed studies, 17 were case studies or case series (see Supplemental Material 1 for additional details including inclusion and exclusion criteria).
An ideal study was defined as one that evaluates the incidence of asthma through a definitive diagnosis (i.e. determined by a physician through standard clinical criteria including lower respiratory tract symptoms and bronchial hyper-responsiveness determined by spirometry before and after bronchodilators and/or methacholine challenge) and quantitatively measures exposures potentially associated with an asthmatic response. The current database, however, contains no such study. No study, to date, has quantitatively linked exposure to asthmatic response. Some studies do use categorical exposure metrics to assess dose-response regarding either the duration of occupational exposure (e.g., de Fatima Macaira et al., 2007) or frequency of product use (e.g., Zock et al., 2007) , but these consider neither specific ingredients nor concentration, hindering their utility for use in safety and risk assessment.
The group of most reliable studies (scored as 1 or 2) considered jointly provide some indication of increased risk of developing asthma and asthma-like symptoms among cleaners, although these findings are not consistent (Table 4 Tables S2 and S3 , for additional study reviews, details and scores); the majority of odds ratios (ORs) are greater than 1, indicating a possible trend of increased risk among cleaners, but the statistical significance of the results is mixed. Moreover, the strength of the significantly positive associations between cleaning and asthma are moderate (i.e., an OR of approximately 2.5 or less), especially in studies that assess physician-diagnosed asthma. This is also generally true for studies that assess self-reported asthma with the exception of MedinaRamon et al. (2005) , which reports an OR of 12 (95%CI 3.2e46) among non-domestic workers. Besides this exception, there is no apparent difference in effect among studies that base their conclusions on physician-diagnosed asthma versus those that rely solely on self-reporting (Table 4) . Combined with a lack of robust dose-response information, the currently available evidence is not sufficient to establish causal relationships between exposure to cleaning agents and new onset asthma. Additional research on exposure, including non-chemical (e.g., aeroallergens, such as pollen or mold) contributions, associated with cleaning tasks is needed.
The epidemiology data, based on the Hill criteria, indicate that there is a positive, but limited relationship between cleaning and asthma due to an inability to establish causality (Table 5) .
Case study: acetic acid
To test our proposed framework, we conducted a case study using acetic acid as an example. Acetic acid was chosen because it is data-rich and commonly used as an ingredient in both commercial and home-made (i.e., vinegar-based) cleaning products, is a known irritant, and was labeled an "asthmagen" by the AOEC (2012).
As indicated in Fig. 1 , the first step of this multi-step hazard characterization approach is to assess, through systematic review, whether there is evidence of a potential asthma hazard in a human This descriptor reflects data sets that are too limited to evaluate the end point.
a Marginal effects are defined as risk ratios or test results (e.g., ANOVA) that are not statistically significant, but are reasonably close (i.e., a p-value of 0.06 or an OR LCL of 0.99). Although these results are not statistically significant, this lack of significance may be due to study design issues, such as insufficient power, or study variability. In order to be health-protective, this method is conservative in its approach and does not consider borderline, or marginal, LCLs or p-values to be strong evidence of a lack of effect. Since this is a screening approach, it is preferred to err on the side of caution and potentially mislabel chemicals as asthma inducers, rather than the converse. exposure environment. As indicated above, the larger database of epidemiological assessments indicated a link between cleaning and asthma. Many cleaning products including acetic acid as an ingredient were used or evaluated in the epidemiological literature. No definitive causal link can be determined from the currently available information on cleaning activities. Therefore, an ingredientspecific hazard assessment is warranted. See section 3 of the supplemental material for a detailed example of this framework using acetic acid as a case study. A summary of the findings is shown in Table 6 . Because this hazard assessment indicates that acetic acid, as neat, undiluted material, is likely to induce or exacerbate asthma, a more definitive safety assessment would be conducted. A scenario-specific safety assessment is presented by Maier et al. (2015) for acetic acid.
Discussion
Framework challenges and considerations
Our systematic review found a positive association between use of domestic cleaning products and asthma response, consistent with the findings of Siracusa et al. (2013) and Folletti et al. (2014) . However, the evidence linking exposure to cleaning agents as a risk factor for causing new onset asthma is limited, based on application of the Hill Criteria (Hill, 1965; Meek et al., 2014) .
3 A number of the Hill Criteria are not fulfilled, specifically consistency/concordance, dose-response, strength of the association, and specificity of the association (Table 5 ). Due to the lack of robust quantitative exposure analysis, no exposure-response relationship between potential exposures and new onset asthma can be ascertained from the currently available data. Moreover, cleaning exposures are not specific to cleaning product ingredients, and may include a number of other potential risk factors, such as increased airborne dust and microbial exposures (Knibbs et al., 2012) . Although the causal relationship between asthma induction and use of cleaning products is unclear, it is biologically plausible and disease prevention strategies should be used until additional information on specific risk factors, effect mechanisms, and exposure characterizations and quantifications is obtained (Siracusa et al., 2013) . There are multiple surrogates for exposure (e.g., the number of products used, or duration of cleaning activity, or employment as a cleaner), but their reliability for characterizing an exposureresponse relationship is uncertain. There are multiple scenarios and circumstances in which surrogate exposure metrics would not account for actual exposures. Specifically, product misuse (e.g., mixing bleach with acids) is not uncommon among cleaners (Medina-Ramon et al., 2005; Zock et al., 2001 ) and may play a large role in the onset of respiratory disease including asthma, as is evidenced by multiple case reports/series (Deschamps et al., 1994; Fig. 4 . The decision-making process used for categorizing the strength of evidence for each individual study and the weight of evidence for a chemical's database of asthma elicitation, respiratory sensitization, or respiratory irritation information. Gorguner et al., 2004; Mapp et al., 2000) . Moreover, categorical exposure assessments are neither capable of considering the various mixtures of chemicals (some of which may be irritants or sensitizers) to which cleaners are exposed nor able to account for how the cleaning process may increase exposure to non-chemically related aeroallergens (i.e., by allowing deposited allergenic particulates to re-suspend in the air).
The lack of a clear causal relationship between general cleaning and asthma induction means that safety and risk assessments need to more fully explore such relationships to inform risk management. A logical common starting point is the safety evaluation of individual consumer product ingredients and their potential for inducing or exacerbating an asthmatic effect. With 2000 new chemicals being introduced every year for use in consumer items (NTP, 2016) , it is impossible to comprehensively assess risks for each use scenario for every possible ingredient. Some screening tools are in development to rapidly predict exposure and dose estimates, specifically ExpoCast (EPA, 2016a) or ConsExpo (RIVM, 2006) which can be compared to toxicity predictions (e.g., ToxCast (EPA, 2016b)). A framework for using and interpreting these tools is provided by Maier et al. (2015) . By using screening and hazard characterization methods, such as the ones presented, safety and risk assessors can identify product ingredients that pose the greatest risk and focus efforts on higher priority assessments.
Data integration methods and weight-of-evidence schemes are not new to safety and risk assessment (e.g., Mohapatra et al., 2010 Mohapatra et al., , 2011 , but no widely accepted approach has been developed specifically for asthma risk assessment. Because of the complexities of asthma, particularly the variation in induction modes of action (i.e., IgE-mediated versus non-IgE-mediated), a one-size-fits-all approach to asthma risk assessment may not be sufficiently protective of human health. There is currently no asthma-specific risk assessment guidance (Maier et al., 2014) , and the use of risk assessment for surrogate endpoints alone (i.e., the IPCS (2012) guidance for immunotoxicity [sensitization] risk assessment) is not sufficiently predictive for asthma induction prevention. The methods proposed here and in Maier et al. (2015) address gaps in asthma risk assessment and provide methods for screening and assessment of possible asthma-inducing chemicals.
Case study: acetic acid
In the case study on acetic acid, we used our proposed framework to 1) score the quality and reliability of individual toxicological and epidemiological studies 2) identify the likelihood that acetic acid causes endpoint-specific effects (e.g., asthma, respiratory sensitization, or respiratory irritation), and 3) identify the overall weight of evidence for asthma induction potential. The results categorize acetic acid as likely to elicit or induce an asthmatic effect and indicate the need for further assessment, using the tiered hazard characterization and exposure assessment approach detailed in Maier et al. (2015) . These findings are consistent with current risk assessment guidance classifications for acetic acid, specifically the European Union's (EU, 2010) determination that acetic acid is irritating and/or corrosive, dependent on concentration, and the AOEC (2012) determination that acetic acid is a respiratory sensitizer and "asthmagen". Additional case studies need to be conducted to further test the validity of this method. chemical is related to asthma responses, or there is mixed or inconclusive evidence of respiratory sensitization and severe irritation, or there is a lack of information on asthma and respiratory sensitization. "Inadequate" is a common descriptor in the asthma category due to the absence of validated animal or in vitro models for this endpoint and does not infer the absence of required safety testing.
However, this approach was designed to be health protective; it is more likely that the approach will falsely identify chemicals as possible asthma inducers rather than miss asthma inducing chemicals through the screening process.
Conclusions
Although the proposed framework is useful for assessing the safety profile of product ingredients, these current efforts do not resolve the many lingering exposure-specific questions encountered in real-world product use scenarios. There are many remaining questions spurred by the lack of quantitative information on task-based and ingredient-specific exposures. Specifically, there are large data gaps concerning the exposure make-up of combined exposures and mixtures (i.e., the use of multiple products or tasks within one room or setting) and temporal patterns (e.g., peak versus chronic exposures). There is growing evidence that non-routine, relatively high (i.e., peak) exposures, as well as chronic lower-concentration exposures, may both contribute to asthma (e.g., RADS or LICEDS). This is consistent with our knowledge of the contributions of long versus short-term patterns of exposure associated with allergic sensitization; both temporal patterns may cause respiratory allergy, but there is insufficient information to determine which pattern is of greatest relevance or concern (Dotson et al., 2015) .
Other key areas of exposure uncertainty relate to the interplay between chemical, biological, and other stressors associated with cleaning. The act of cleaning may temporarily increase airborne dust and microbial exposures (Knibbs et al., 2012) , but the use of cleaning products (e.g., bleach) reduces the levels of aeroallergens and asthma triggers (e.g., mold, mildew, pet dander, dust, mites) in the home over time. It may have a net beneficial effect by reducing aeroallergen-specific atopy and the risk of asthma induction or elicitation (Zock et al., 2009; Nickmilder et al., 2007; Hern andezCadena et al., 2015; Hu et al., 2014) . Although some sensitizing and/or irritant product components may increase the risk of developing asthma, multiple studies show that cleaning, and the use of specific cleaning products like bleach, may actually decrease the risk of developing asthma by reducing exposure to other known household allergens (Barnes et al., 2008; Zock et al., 2009; Chen and Eggleston, 2001; Matsui et al., 2003; Nickmilder et al., 2007) . Overall, the use of cleaning products may reduce the risk of IgE mediated asthma associated with living in a "dirty" environment while possibly increasing the risk of asthma induction or elicitation Tables S2 and S3 for additional study reviews, details, and rationales for score selection. b Results are reported for workers with occupational asthma. Information on work-exacerbated asthma is presented in the supplemental material.
through chemical-induced sensitization or irritation of the respiratory tract. There is, hypothetically, a balance between the use of cleaning products to reduce mold, mildew, dust, and dander levels that would not increase the risk of asthma induction or elcitiation associated with cleaning product use resulting in the minimum asthma risk. One goal, in chemical safety assessment, is to identify the product ingredients that pose the greatest potential to induce or elicit asthma and seek to decrease their use or promote use of alternate, inherently safer products. Hazard-based approaches are intended to decrease the asthma risk associated with cleaning products. However, use of such approaches on an ingredient-byingredient basis will likely fall short of informing actual risk during product use e which requires knowledge of exposure-response relationships and data on modifying factors (such bioaerosol levels from cleaning) that impact the overall risk for a specified activity. 5 . A forest plot depicting the results (ORs with 95% CI) for reliable (score 1 or 2) studies that examine the relationship between general cleaning tasks and physician-diagnosed asthma. See Supplemental Material for additional study reviews and details.
Table 5
Application of the Hill criteria to the epidemiological database on cleaning and asthma.
Criterion Conclusion
Concordance/ Consistency
Inadequate e the data have mixed results amongst studies with the highest reliability (i.e., physician-diagnosed asthma with a score of 1 or 2) Dose-Response Limited e no quantitative dose-response information available. Some qualitative information available Strength Limited -odds ratios were typically moderate, but not strong, suggesting limited strength Temporality Strong e some longitudinal studies are available Plausibility Strong e our knowledge of the mechanism of asthma induction and elicitation include irritant and sensitization responses. Some cleaning product ingredients show these characteristics. Specificity
Limited e there are many causes of asthma and other household (e.g., mold, dander, pollen) and individual susceptibilities (e.g., atopy, exercise) are predictive of asthma outcomes.
A potential next step in the safety and risk assessment process is to collect data and establish a field experimental protocol that allows for evaluating quantitative exposure response relationships to chemicals and non-chemical asthma inducers in real world scenarios relevant to consumer product uses. Such data can: 1) clarify the extant significant body of epidemiology by supporting retrospective exposure estimates, 2) support improvements to current exposure modeling tools, 3) move the field of asthma safety and risk assessment forward by developing an approach for considering cumulative risks of complex real-life exposures, 4) provide an additional empirical protocol for safety and risk assessment that could be added to the suite of tools described in Maier et al. (2015) for scenarios when exposure data are inadequate for making effective risk management decisions. 
